vTv Therapeutics (VTVT) Research & Development (2014 - 2026)
vTv Therapeutics (VTVT) reported Research & Development of $8.77 million for Q2 2026, up 113.7% from $4.1 million a year earlier but down 2.3% from the prior quarter.
Powered by 
Analysis
vTv Therapeutics (VTVT) Research & Development (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, vTv Therapeutics' Research & Development came in at $28.68 million, up 131.4% year-over-year; for FY2025, it came in at $17.86 million, up 54.7% from FY2024.
- Research & Development has a five-year compound annual growth rate of 10.1% (FY2020 to FY2025).
- By year, Research & Development came in at $11.55 million in FY2024 (-15.1%), $13.6 million in FY2023 (+10.0%), $12.36 million in FY2022 (-7.3%) and $13.32 million in FY2021 (+21.0%).
- Five-year quarterly Research & Development spans a low of $2.14 million in Q4 2023 and a high of $8.98 million in Q1 2026.
- Year over year, Research & Development has now increased in each of the last eight quarters, with growth averaging 71.1% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q1 2026 (growth of 217.2%); the low point was Q4 2023 (a decline of 46.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.98 million (Q1 2026), $3.91 million (Q4 2025) and $7.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | vTv Therapeutics | 378.73 Mn | 378.73 Mn | - | 8.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.77 Mn |
| Mar 31, 2026 | 8.98 Mn |
| Dec 31, 2025 | 3.91 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Jun 30, 2023 | 4.69 Mn |
| Mar 31, 2023 | 3.94 Mn |
| Dec 31, 2022 | 3.96 Mn |
| Sep 30, 2022 | 3.06 Mn |
| Jun 30, 2022 | 2.21 Mn |
| Mar 31, 2022 | 3.13 Mn |
| Dec 31, 2021 | 5.40 Mn |
| Sep 30, 2021 | 2.38 Mn |
API Access
vTv Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VTVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VTVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VTVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();